Condition
Epigastric Pain Syndrome
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 4 (2)
Trial Status
Completed1
Not Yet Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07165301Not Yet Recruiting
Postprandial Distress Itopride Cohort Trial
NCT00673972Phase 4Withdrawn
Comparative Study of Epigastric Pain Syndrome and Postprandial Distress Syndrome
NCT00663897Phase 4Completed
Lansoprazole Versus Mosapride for Functional Dyspepsia
Showing all 3 trials